Ernesto Cason
Overview
Explore the profile of Ernesto Cason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
158
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giannoccaro M, Donadio V, Giannini G, Devigili G, Rizzo G, Incensi A, et al.
Parkinsonism Relat Disord
. 2020 Oct;
81:48-53.
PMID: 33049589
Introduction: Cardiac [123I]metaiodobenzylguanidine scintigraphy (123I-MIBG) is considered a useful test in differentiating multiple system atrophy (MSA) and Lewy body disorders (LBD), including idiopathic Parkinson's disease (IPD), dementia with Lewy bodies...
2.
Terlizzi R, Calandra-Buonaura G, Zanigni S, Barletta G, Capellari S, Guaraldi P, et al.
Auton Neurosci
. 2016 Feb;
195:20-6.
PMID: 26896090
Background And Purpose: Adult-onset autosomal dominant leukodystrophy (ADLD) is a rare progressive neurological disorder caused by Lamin B1 duplication (LMNB1). Our aim was to investigate longitudinally the pattern of the...
3.
Giannoccaro M, Donadio V, Incensi A, Pizza F, Cason E, Di Stasi V, et al.
Mov Disord
. 2015 Mar;
30(7):986-9.
PMID: 25778097
Background: (123) I-meta-iodobenzylguanidine ((123) I-MIBG) myocardial scintigraphy is considered reliable in differentiating idiopathic Parkinson's disease (IPD) from other parkinsonisms, but it is biased by pharmacological treatments. Skin biopsy is not...
4.
Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, et al.
J Neuroimaging
. 2012 Nov;
24(2):149-54.
PMID: 23163913
Purpose: To compare myocardial sympathetic imaging using (123)I-Metaiodobenzylguanidine (MIBG) scintigraphy and striatal dopaminergic imaging using (123)I-Ioflupane (FP-CIT) single photon emission computed tomography (SPECT) in patients with suspected Lewy body diseases...
5.
Treglia G, Cason E
Parkinsonism Relat Disord
. 2012 May;
18(6):805.
PMID: 22575232
No abstract available.
6.
Treglia G, Cason E, Giordano A, Fagioli G
Parkinsonism Relat Disord
. 2012 Mar;
18(5):707-8.
PMID: 22425545
No abstract available.
7.
Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A
Clin Neurol Neurosurg
. 2011 Oct;
113(10):823-9.
PMID: 21962800
Background And Purpose: This study was designed to review the diagnostic performance of iodine-123-metaiodobenzylguanidine (MIBG) scintigraphy in differential diagnosis between Parkinson's disease (PD) and multiple-system atrophy (MSA). Methods: A comprehensive...
8.
Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al.
Clin Auton Res
. 2011 Jul;
22(1):43-55.
PMID: 21792729
Objective: Differential diagnosis between Parkinson's disease (PD) and other Parkinsonism using clinical criteria or imaging methods is often difficult. The purpose of this study is to systematically review and meta-analyze...
9.
Treglia G, Cason E
J Neuroimaging
. 2010 Nov;
22(2):111-7.
PMID: 21091814
Background And Purpose: This study was designed to review the diagnostic performance of myocardial innervation imaging using iodine-123-metaiodobenzylguanidine (MIBG) scintigraphy in differential diagnosis between dementia with Lewy bodies (DLB) and...
10.
Treglia G, Cason E, Gabellini A, Giordano A, Fagioli G
Neurol Sci
. 2010 Mar;
31(4):417-22.
PMID: 20221656
Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be...